Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q1 2026 (March 31)11holders −1
1new positions
2sold out
$24.62avg. 13F price*
At the end of Q1 2026, 11 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 2 sold out. The largest holders were FMR LLC ($18.0M), Wealth Enhancement Advisory Services, LLC ($9.5M) and Jane Street Group, LLC ($1.3M).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 2 | $31K |
All 13F filers, Q4 2025 → Q1 2026: 5,622 shares bought and 368,388 shares sold, net −362,766 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| FMR LLC | 0.00% | Reduce 0.0% | 732,972 | $18.0M |
| Wealth Enhancement Advisory Services, LLC | 0.02% | Reduce -46.0% | 386,395 | $9.5M |
| Jane Street Group, LLC | 0.00% | Reduce -41.9% | 53,106 | $1.3M |
| Virtu Financial LLC | 0.01% | Add +65.7% | 13,956 | $343K |
| Vise Technologies, Inc. | 0.00% | No change | 8,648 | $234K |
| BXM Wealth LLC | 0.16% | Reduce -3.3% | 8,690 | $213K |
| Glass Jacobson Investment Advisors llc | 0.01% | No change | 1,260 | $31K |
| UBS Group AG | 0.00% | Add +4.5% | 231 | $6K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $2K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
| Royal Bank of Canada | 0.00% | New | 80 | $2K |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.